NCT05579223View on ClinicalTrials.gov

Intrathecal Hydromorphone for Postoperative Pain of Anorectal Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

January 24, 2024

Study Completion Date

January 27, 2024

Conditions
Acute PainPost Operative PainAnorectal DisorderAnalgesia
Interventions
DRUG

Intrathecal Hydromorphone Mono Injection

Experimental Drug: Hydromorphone Hydrochloride Injection. Administration: subarachnoid space mono bolus inject, + 5% glucose injection diluted to 75 μg:1.5ml, Speed ≤ 0.5 ml/s

DRUG

Intrathecal Placebo Mono Injection

Placebo: 5% glucose injection. Administration: subarachnoid space mono bolus inject, 1.5ml, Speed ≤ 0.5 ml/s

Trial Locations (1)

20092

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER